Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-26

Clinical Trial Update: Study of Exchange of Travoprost Intraocular Implant [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating exchange of travoprost intraocular implant for open-angle glaucoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Travoprost intraocular implant (travoprost)

Snippet

Sponsor: Glaukos Corporation | Conditions: Open Angle Glaucoma | Phase 2 | Status: COMPLETED | Results posted: 2023-09-26